On May 28, Core Scientific rose 5.01% in regular trading, trading at $27.61/share, with trading volume of approximately $308 million.
On the news front, B.Riley raised the company's target price from $30 to $33 while maintaining a buy rating. The analyst consensus target price now stands at $30.12. Additionally, the company has recently filed multiple Form 4 and Schedule 13G/A documents, indicating continued institutional investor position changes and sustaining market expectations of capital inflows.
Within the Application Software sector, computing power-related stocks exhibited strong linkage gains, with IREN Ltd up 13.3% and AppLovin Corporation up 11.3%, providing effective support for Core Scientific's upward momentum. The stock has continued to trade above the prior analyst consensus target of $24, reflecting strengthened institutional confidence following the target price upgrade.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments